美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
72516-014-01	72516-014	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20201019	N/A	ANDA	ANDA210293	Oryza Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	2.5 mg/1; 2.5 mg/1; 2.5 mg/1; 2.5 mg/1	100 TABLET in 1 BOTTLE (72516-014-01)
72516-015-01	72516-015	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20201019	N/A	ANDA	ANDA210293	Oryza Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.875 mg/1; 1.875 mg/1; 1.875 mg/1; 1.875 mg/1	100 TABLET in 1 BOTTLE (72516-015-01)
72516-016-01	72516-016	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20201019	N/A	ANDA	ANDA210293	Oryza Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	1.25 mg/1; 1.25 mg/1; 1.25 mg/1; 1.25 mg/1	100 TABLET in 1 BOTTLE (72516-016-01)
72516-013-01	72516-013	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20201019	N/A	ANDA	ANDA210293	Oryza Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	3.75 mg/1; 3.75 mg/1; 3.75 mg/1; 3.75 mg/1	100 TABLET in 1 BOTTLE (72516-013-01)
72516-012-01	72516-012	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20201019	N/A	ANDA	ANDA210293	Oryza Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	5 mg/1; 5 mg/1; 5 mg/1; 5 mg/1	100 TABLET in 1 BOTTLE (72516-012-01)
72516-011-01	72516-011	HUMAN PRESCRIPTION DRUG	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate	TABLET	ORAL	20201019	N/A	ANDA	ANDA210293	Oryza Pharmaceuticals Inc.	AMPHETAMINE ASPARTATE MONOHYDRATE; AMPHETAMINE SULFATE; DEXTROAMPHETAMINE SACCHARATE; DEXTROAMPHETAMINE SULFATE	7.5 mg/1; 7.5 mg/1; 7.5 mg/1; 7.5 mg/1	100 TABLET in 1 BOTTLE (72516-011-01)